ruxolitinib

Italy

Drugs containing this active substance

  • JAKAVI

    Jakavi is used to treat adults with myelofibrosis (a rare form of blood cancer) who have an enlarged spleen or related symptoms, and adults with polycythemia vera who do not tolerate or are resistant to hydroxyurea. It is also indicated for children and adults with graft-versus-host disease (GvHD) in its acute and chronic forms.

    Form: tablets

    Active substance Dosage
    ruxolitinib -

    ATC: L01EJ01

    Manufacturer: NOVARTIS EUROPHARM LIMITED

  • OPZELURA

    It is used on the skin to treat facial vitiligo in adults and adolescents aged 12 years and older.

    Form: cream

    Active substance Dosage
    ruxolitinib -

    ATC: D11AH09

    Manufacturer: INCYTE BIOSCIENCES DISTRIBUTION B.V.

  • RUXOLITINIB VIVANTA

    This medicine is used to treat adults with an enlarged spleen or symptoms related to myelofibrosis. It is also indicated for adults with polycythemia vera who do not tolerate or are resistant to hydroxyurea, and for children (from 28 days of age and older for the acute form and from 6 months of age and older for the chronic form) and adults with graft-versus-host disease (GvHD).

    Form: tablets

    Active substance Dosage
    ruxolitinib -

    ATC: L01EJ01

    Manufacturer: VIVANTA GENERICS S.R.O.